Related Experiment Video
Updated: Aug 14, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 15, 2011
Diagnosis and management of histoplasmosis
1Indiana University School of Medicine, Wishard Memorial Hospital, Indianapolis, Indiana 46202.
Abstract:
Histoplasmosis occurs throughout the world but is more common within the endemic areas of North America, particularly in fertile river valleys. Disease manifestations range from asymptomatic infection in the normal host with low-inoculum exposure to rapidly fatal, disseminated infection in the severely immunocompromised host, emphasizing the importance of cellular immunity in defense against Histoplasma capsulatum. Diagnosis depends on a high index of suspicion, knowledge of the clinical and epidemiologic features of the infection, and a thorough understanding of the uses and limitations of fungal cultural and serological laboratory procedures. Recently, a method has been developed for rapid diagnosis based on detection of a polysaccharide antigen in body fluids of patients with histoplasmosis. Amphotericin B remains the preferred treatment for more severe forms of histoplasmosis, particularly in the immunocompromised host, but oral treatment with ketoconazole or newer imidozoles appears to be effective in less severe infections in non-immunocompromised individuals.
Insights
Histoplasmosis, a fungal infection, presents varied severity based on host immunity. Rapid diagnosis via antigen detection and effective treatments like Amphotericin B are crucial for managing this Histoplasma capsulatum disease.
Area of Science:
- Mycology and Infectious Diseases
- Immunology
- Clinical Diagnostics
Background:
- Histoplasmosis is a globally occurring fungal infection, endemic to North America, with disease severity spectrum influenced by host immunity.
- Cellular immunity is critical in defending against Histoplasma capsulatum, with manifestations ranging from asymptomatic to rapidly fatal disseminated disease.
- Traditional diagnosis relies on clinical suspicion, epidemiological data, and laboratory methods (fungal cultures, serology), each with limitations.
Purpose of the Study:
- To highlight the diagnostic challenges and advancements in Histoplasmosis detection.
- To review the current understanding of Histoplasmosis pathogenesis and host defense mechanisms.
- To summarize therapeutic strategies for Histoplasmosis, differentiating between severe and less severe forms.
Main Methods:
- Review of clinical, epidemiological, and laboratory diagnostic features of Histoplasmosis.
- Discussion of the role of cellular immunity in Histoplasma capsulatum infections.
- Evaluation of diagnostic methods including fungal cultures, serology, and novel antigen detection techniques.
- Assessment of treatment outcomes for Amphotericin B and oral azoles (ketoconazole, newer imidazoles).
Main Results:
- A new rapid diagnostic method detecting a polysaccharide antigen in body fluids has been developed.
- Amphotericin B is the primary treatment for severe and disseminated Histoplasmosis, especially in immunocompromised patients.
- Oral ketoconazole and newer imidazoles show efficacy in treating less severe Histoplasmosis in non-immunocompromised individuals.
Conclusions:
- Early and accurate diagnosis of Histoplasmosis is essential, with antigen detection offering a promising rapid approach.
- Treatment strategies for Histoplasmosis must be tailored to disease severity and host immune status.
- Understanding the interplay between Histoplasma capsulatum and the host immune system is key to managing this infection.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Rocky Mountain Spotted Fever
Cryptococcal Meningitis
Toxoplasmosis
Trichomoniasis

